Balance Sheet
Liabilities and Shareholders Equity
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

KalVista Pharmaceuticals (KALV) Other Non-Current Liabilities (2024)

KalVista Pharmaceuticals' Other Non-Current Liabilities history spans 3 years, with the latest figure at $4.4 million for Q4 2024.

  • For Q4 2024, Other Non-Current Liabilities changed N/A year-over-year to $4.4 million; the TTM value through Dec 2024 reached $4.4 million, changed N/A, while the annual FY2014 figure was $1.5 million, N/A changed from the prior year.
  • Other Non-Current Liabilities for Q4 2024 was $4.4 million at KalVista Pharmaceuticals, up from $2.3 million in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $4.4 million in Q4 2024 and bottomed at $4.4 million in Q4 2024.